Past, present, and future of Parkinson's disease: A special essay on the 200th Anniversary of the Shaking Palsy

Obeso, J.A., Stamelou, M., Goetz, C.G., Poewe, W., Lang, A.E., Weintraub, D., Burn, D., Halliday, G.M. +30 more·2017·Movement Disorders
DOI 10.1002/mds.27115

Cited by (736)

Items 401–500 of 736

  1. nnEfficacy and safety of istradefylline for Parkinson's disease: A systematic review and meta-analysis.
    Xiao-Le Wang, Si-Tong Feng, Bin Chen, Die Hu, Zhenzhen Wang, Yi Zhang · 2022 · Neuroscience Letters
  2. Does the Montreal Cognitive Assessment (MoCA) identify cognitive impairment profiles in Parkinson’s disease? An exploratory study
    M. Castelli, L. Alonso-Recio, F. Carvajal, J. M. Serrano · 2021 · Applied neuropsychology. Adult
  3. Genetic predisposition to Parkinson's disease and risk of cardio and cerebrovascular disease: a Mendelian randomization study
    Mengmeng Wang, Zhizhong Zhang, Dandan Liu, Lei Ji, Shuangjiao Huang, Liping Cao, Ning Wei, Dan Ye, Yazhou Ma, Xuegan Lian · 2021 · Parkinsonism & Related Disorders
  4. An Emerging Role for Phosphoinositides in the Pathophysiology of Parkinson’s Disease
    Meir Schechter, Ronit Sharon · 2021 · Journal of Parkinson s Disease
  5. Bu-Yin-Qian-Zheng Formula Ameliorates MPP+-Induced Mitochondrial Dysfunction in Parkinson’s Disease via Parkin
    Haojie Ma, Cong Gai, Yuan Chai, Wan-Di Feng, Cuicui Cheng, Jinkun Zhang, Yuxin Zhang, Luping Yang, Zhenyu Guo, Yu-Shan Gao et al. · 2020 · Frontiers in Pharmacology
  6. Novel Drosophila model for parkinsonism by targeting phosphoglycerate kinase
    Joe Shimizu, Takashi Kasai, Hideki Yoshida, Man Anh Huynh, Yumiko Nakao-Azuma, Makiko Shinomoto, Takahiko Tokuda, Toshiki Mizuno, Masamitsu Yamaguchi · 2020 · Neurochemistry International
  7. Purified anacardic acids exert multiple neuroprotective effects in pesticide model of Parkinson's disease: in vivo and in silico analysis
    Ricielle Lopes Augusto, Ingrid Prata Mendonça, Gabriel N. A. Rego, Danielle Dutra Pereira, Lílian Vanessa da Penha Gonçalves, Maria Lucília dos Santos, Raphael Fabrício de Souza, Giselle Machado Magalhães Moreno, Pablo Ramon Gualberto Cardoso, Daniele de Souza Andrade et al. · 2020 · IUBMB Life
  8. Quantitative Susceptibility Mapping and Resting State Network Analyses in Parkinsonian Phenotypes—A Systematic Review of the Literature
    E. A. Pelzer, E. Florin, A. Schnitzler · 2019 · Front. Neural Circuits
  9. Exploring the Mitochondrial Degradome by the TAILS Proteomics Approach in a Cellular Model of Parkinson’s Disease
    Marta Lualdi, Maurizio Ronci, Mara Zilocchi, Federica Corno, Emily Samuela Turilli-Ghisolfi, Mauro Sponchiado, Antonio Aceto, Tiziana Alberio, Mauro Fasano · 2019 · Frontiers in Aging Neuroscience
  10. Cognitive and behavioral assessment in Parkinson’s disease
    Saül Martínez‐Horta, Andrea Horta‐Barba, Jaime Kulisevsky · 2019 · Expert Review of Neurotherapeutics
  11. Male sex accelerates cognitive decline in GBA1 Parkinson’s disease
    Silvia Paola Caminiti, Micol Avenali, Alice Galli, Rachele Malito, Giada Cuconato, Caterina Galandra, Rosaria Calabrese, Andrea Pilotto, Alessandro Padovani, Fabio Blandini et al. · 2025 · npj Parkinson s Disease
  12. Extract from Nasco pomace loaded in nutriosomes exerts anti-inflammatory effects in the MPTP mouse model of Parkinson's disease
    Pathik Parekh, Marcello Serra, Mohamad Allaw, Matteo Perra, Annalisa Pinna, Maria Manconi, Micaela Morelli · 2024 · Experimental Neurology
  13. Deep Brain Stimulation Mechanisms in Parkinson's Disease: Immediate and Long-Term Effects.
    Honglong Pei, Zhenghan Wu, Li Ma, Jun Wang, Jing-Hui Li, Xin Geng, Yang-Hong Zou, Mou Zhang, Renli Qi, Hua-Lin Yu · 2024 · Journal of Integrative Neuroscience
  14. Development of a multi-sensor integrated midbrain organoid-on-a-chip platform for studying Parkinson’s disease
    Sarah Spitz, Silvia Bolognin, Konstanze Brandauer, Julia Füßl, Patrick Schuller, Silvia Schobesberger, Christian Jordan, Barbara Schädl, Johannes Grillari, Heinz D. Wanzenboeck et al. · 2022 · bioRxiv (Cold Spring Harbor Laboratory)
  15. The Utility of Breath Analysis in the Diagnosis and Staging of Parkinson’s Disease
    Simon R. W. Stott, Y. Broza, A. Gharra, Zhen Wang, R. Barker, H. Haick · 2022 · Journal of Parkinson's Disease
  16. Synthesis and evaluation of methoxy substituted 2-benzoyl-1-benzofuran derivatives as lead compounds for the development adenosine A1 and/or A2A receptor antagonists.
    Helena D. Janse van Rensburg, L. Legoabe, G. Terre'Blanche, J. Aucamp · 2019 · Bioorganic chemistry (Print)
  17. Uridine Prevents Negative Effects of OXPHOS Xenobiotics on Dopaminergic Neuronal Differentiation
    Eldris Iglesias, M. Pilar Bayona‐Bafaluy, Alba Pesini, Nuria Garrido-Pérez, Patricia Meade, Paula Gaudó, Irene Jiménez-Salvador, Julio Montoya, Eduardo Ruiz‐Pesini · 2019 · Cells
  18. Motor Improvement-Related Regional Cerebral Blood Flow Changes in Parkinson's Disease in Response to Antiparkinsonian Drugs
    S. Taguchi, N. Tanabe, Jun-Ichi Niwa, M. Doyu · 2019 · Parkinson's Disease
  19. PLEKHM1 Overexpression Impairs Autophagy and Exacerbates Neurodegeneration in rAAV-α-Synuclein Mice
    Lennart Höfs, David Geißler-Lösch, Björn H. Falkenburger · 2025 · Cells
  20. Low-intensity transcranial ultrasound neuromodulation promotes neuronal regeneration: A new hope for noninvasive treatment of neurodegenerative diseases
    Shu Xia, Chen He, Yunfei Li, Hao Li, Bo Wang, Long Xu, Xudong Zhao · 2025 · Neural Regeneration Research
  21. Validation of the International Parkinson and Movement Disorder Society Non‐Motor Symptoms Questionnaire (MDS‐NMS‐Q)
    Daniel Weintraub, K. R. Chaudhuri, A. Schrag, P. Martinez-Martin, A. Rizos, E. Mamikonyan, Julia Gallagher, Izabelle Schoen, J. Staunton, Marta Fernandes et al. · 2025 · Movement Disorders
  22. The impact of motor, non-motor, and social aspects on the sexual health of women living with Parkinson's disease
    Kátia Cirilo Costa Nóbrega, Isaíra Almeida Pereira da Silva Nascimento, Bruno Rafael Antunes Souza, Raíssa Amorim Gonçalves, Thalyta Silva Martins, Geovanna Ferreira Santos, Bruno Eron de Almeida da Silva, André Frazão Helene, Antônio C. Roque, Rodolfo Savica et al. · 2025 · Journal of Parkinson s Disease
  23. p75NTR Modulation by LM11A-31 Counteracts Oxidative Stress and Cholesterol Dysmetabolism in a Rotenone-Induced Cell Model of Parkinson’s Disease
    Daniele Pensabene, Noemi Martella, Giuseppe Scavo, Emanuele Bisesto, Francesca Cavicchia, Mayra Colardo, Michela Varone, Sandra Moreno, Marco Segatto · 2025 · Neurochemical Research
  24. HucMSC extracellular vesicles increasing SATB 1 to activate the Wnt/β‐catenin pathway in 6‐ OHDA ‐induced Parkinson's disease model
    Ying He, Ruicheng Li, Yuxi Yu, Zhiran Xu, Jiaxin Gao, Cancan Wang, Chusheng Huang, Zhongquan Qi · 2024 · IUBMB Life
  25. fMRI changes during multi-limb movements in Parkinson’s disease
    Jae Woo Chung, Abigail E. Bower, I. Malik, Justin P. Martello, Christopher A. Knight, John J. Jeka, Roxana G. Burciu · 2023 · Frontiers in Human Neuroscience
  26. Shared and Unique Disease Pathways in Amyotrophic Lateral Sclerosis and Parkinson’s Disease Unveiled in Peripheral Blood Mononuclear Cells
    Marta Lualdi, Federico Casale, Mario Giorgio Rizzone, Maurizio Zibetti, Chiara Monti, Ilaria Colugnat, Andrea Calvo, Giovanni De Marco, Cristina Moglia, Giuseppe Fuda et al. · 2023 · ACS Chemical Neuroscience
  27. Sortilin acts as an endocytic receptor for α‐synuclein fibril
    Shun Ishiyama, Takafumi Hasegawa, Naoto Sugeno, Junpei Kobayashi, Shun Yoshida, Yasuo Miki, Koichi Wakabayashi, Mitsunori Fukuda, Yasushi Kawata, Takaaki Nakamura et al. · 2023 · The FASEB Journal
  28. Imaging the lower limb network in Parkinson’s disease
    Jae Woo Chung, Abigail E. Bower, I. Malik, Justin Martello, Chris Knight, J. Jeka, Roxana G. Burciu · 2023 · NeuroImage: Clinical
  29. Protection and Repair of the Nigrostriatal Pathway with Stem-Cell-Derived Carotid Body Glomus Cell Transplants in Chronic MPTP Parkinsonian Model
    Javier Villadiego, A. B. Muñoz-Manchado, Verónica Sobrino, V. Bonilla-Henao, Nela Suárez-Luna, Patricia Ortega-Sáenz, R. Pardal, J. López-Barneo, J. Toledo-Aral · 2023 · International Journal of Molecular Sciences
  30. Dynamic Involvement of Striatal NG2-glia in L-DOPA Induced Dyskinesia in Parkinsonian Rats: Effects of Doxycycline
    Glauce Crivelaro Nascimento, Mariza Bortolanza, Ana Bribián, Gabrielli Leal-Luiz, Rita Raisman‐Vozari, Laura López‐Mascaraque, Elaine Aparecida Del Bel · 2023 · ASN NEURO
  31. Manual and semi-automated approaches to MIBG myocardial scintigraphy in patients with Parkinson’s disease
    C. Boccalini, Giulia Carli, E. G. Vanoli, Antoniangela Cocco, A. Albanese, V. Garibotto, D. Perani · 2022 · Frontiers in Medicine
  32. Zinc Deficiency Exacerbates Behavioral Impediments and Dopaminergic Neuron Degeneration in a Mouse Model of Parkinson Disease
    Xiong Zhang, Ke Wang, Xiaoli Ren, Mengdi Zhang, Kai-Nian Wu, Han Wu, Zhong-Wei Chu, Shu-Shu Liu, Xiao-Xia Jiang, Jian‐Hong Zhu et al. · 2022 · Journal of Nutrition
  33. A multiplex pedigree with pathologically confirmed multiple system atrophy and Parkinson’s disease with dementia
    Alessandra Fanciulli, Fabian Leys, Fabienne Lehner, Victoria Sidoroff, Viktoria Ruf, Cecilia Raccagni, Philipp Mahlknecht, Demy J.S. Kuipers, Wilfred F. J. van IJcken, Heike Stockner et al. · 2022 · Brain Communications
  34. Striatal dopamine transporter imaging in Parkinson’s disease drug-naïve patients: focus on sexual dysfunction
    E. Contaldi, L. Magistrelli, Silvia Gallo, C. Comi · 2022 · Neurological Sciences
  35. The Effects of Non-Invasive Brain Stimulation on Quantitative EEG in Patients With Parkinson's Disease: A Systematic Scoping Review
    Thaísa Dias de Carvalho Costa, C. Godeiro, R. A. E. Silva, Silmara Freitas dos Santos, D. G. da Silva Machado, S. Andrade · 2022 · Frontiers in Neurology
  36. Extension of community healthcare outcomes in Parkinson disease (Parkinson ECHO): A feasibility study
    Lee E. Neilson, J. Wilhelm, M. Mcdonnell, L. Mann, J. Kraakevik · 2022 · medRxiv
  37. Deep Brain Stimulation Can Differentiate Subregions of the Human Subthalamic Nucleus Area by EEG Biomarkers
    Daniel Sand, D. Arkadir, Muneer Abu Snineh, O. Marmor, Z. Israel, H. Bergman, S. Hassin-Baer, S. Israeli-korn, Z. Peremen, A. Geva et al. · 2021 · Frontiers in Systems Neuroscience
  38. Antiparkinsonian drugs as potent contributors to nocturnal sleep in patients with Parkinson’s disease
    S. Taguchi, Hirofumi Koide, H. Oiwa, M. Hayashi, Kazuhiro Ogawa, C. Ito, Koji Nakashima, T. Yuasa, A. Yasumoto, Hiroaki Ando et al. · 2021 · PLoS ONE
  39. Fyn Knock-Down Prevents Levodopa-Induced Dyskinesia in a Mouse Model of Parkinson’s Disease
    Melina Bordone, Ana Damianich, Alejandra Bernardi, Tomas Eidelman, Sara Sanz‐Blasco, Oscar S. Gershanik, María Elena Avale, Juan Esteban Ferrario · 2021 · eNeuro
  40. A Novel Management Platform Based on Personalized Home Care Pathways for Medicine Management and Rehabilitation of Persons With Parkinson's Disease—Requirements and Implementation Plan of the Care-PD Program
    Song Gao, Yuning Hou, Renyan Ma, Keneilwe Kenny Kaudimba, Ling-Jing Jin, Han Wang, Ru Wang · 2021 · Frontiers in Neurology
  41. Regulatory rare variants of the dopaminergic gene ANKK1 as potential risk factors for Parkinson’s disease
    Estela Pérez-Santamarina, P. García-Ruiz, D. Martínez-Rubio, M. Ezquerra, Irene Pla-Navarro, J. Puente, M. Marti, F. Palau, J. Hoenicka · 2021 · Scientific Reports
  42. A New Tool to Study Parkinsonism in the Context of Aging: MPTP Intoxication in a Natural Model of Multimorbidity
    Lorena Cuenca‐Bermejo, Elisa Pizzichini, V Gonçalves, María Guillén-Díaz, Elena Aguilar-Moñino, Consuelo Sánchez-Rodrigo, Ana María González Cuello, Emiliano Fernández‐Villalba, María Trinidad Herrero · 2021 · International Journal of Molecular Sciences
  43. Enfermedad de Parkinson: actualización de estudios preclínicos con el uso de células troncales pluripotentes inducidas
    V. Valadez-Barba, Karen J. Juárez-Navarro, Eduardo Padilla‐Camberos, Néstor Fabián Díaz, José Raúl Guerra-Mora, Nestor Emmanuel Diaz-Martinez · 2021 · Neurología
  44. Quality of Life in Newly Diagnosed Patients With Parkin-Related Parkinson's Disease
    Xin-Yue Zhou, Feng-Tao Liu, Chen Chen, Su-Shan Luo, Jue Zhao, Yi-Lin Tang, Bo Shen, Wen-Bo Yu, Chuan-Tao Zuo, Jian-Jun Wu et al. · 2020 · Frontiers in Neurology
  45. Decoding Parkinson's disease – iPSC-derived models in the OMICs era
    Florian Krach, Marios Bogiongko, Beate Winner · 2020 · Molecular and Cellular Neuroscience
  46. Dermatoses in parkinsonism: the importance of multidisciplinary follow-up
    Isadora Antunes, Kátia Sheylla Malta Purim, Luara Leticia Grande, Nathália Cristina Alberton, Tatiana Francinne Regis Navarro, Thereza Cristina d’Ávila Winckler · 2019 · Revista da Associação Médica Brasileira
  47. Neuroprotective Effects of Time‐Restricted Feeding Combined With Different Protein Sources in MPTP‐Induced Parkinson's Disease Mice Model and Its Modulatory Impact on Gut Microbiota Metabolism
    Ting Li, Jian Wu, Sheng‐Yang Zhou, Ming‐An Li, Li‐Ping Zhao, Ao Wang, Yi‐Zhi Song, Wen‐Yan Huang, Lu‐Lu Tan, Chen-Meng Qiao et al. · 2026 · Advanced Science
  48. Levodopa–Carbidopa–Entacapone Intestinal Gel for Advanced Parkinson’s Disease—Results from a Monocentric Study Evaluating Both Motor and Non-Motor Manifestations
    M Lungu, Violeta Diana Oprea, Luminița Lăcrămioara Apostol, Eva Maria Elkan, Ana Maria Ionescu, Anca Tudor, Andrei Lucian Zaharia · 2025 · Biomedicines
  49. Astrocyte FGF7/FGFR2 autocrine signaling mediates neuroinflammation and promotes MPTP-induced degeneration of dopaminergic neurons
    Xin Sun, Yueping Wang, Yajie Zhang, Ruixue Han, Min Wang, Jing Zhang, Ting Sun, Yang Liu, Gang Hu, Lei Cao et al. · 2025 · Acta Pharmaceutica Sinica B
  50. The arrow of time in Parkinson’s disease
    Fatemeh Sadeghi, Elvira del Agua, Alessandra Pizzuti, Abdullah Okar, Kai Grimm, Christian P Gerloff, Morten L. Kringelbach, Rainer Goebel, Simone Zittel, Gustavo Deco · 2025 · NeuroImage Clinical
  51. Diagnostic work up when suspecting early onset Parkinson disease (EOPD). Recommendations from the MDS EOPD study group.
    R. Mehanna, C. Marras, J. Fleisher, Bart Post, K. Kumar, A. Noyce, R. Alcalay, H. Morris, T. Hatano, M. Salari et al. · 2025 · Parkinsonism & Related Disorders
  52. Mesencephalic astrocyte-derived neurotrophic factor inhibits neuroinflammation through autophagy-mediated α-synuclein degradation
    Kai-Ge Zhou, Yi-Bin Huang, Ziwen Zhu, Ming Jiang, Lingjing Jin, Qiang Guan, Lulu Tian, Jingxing Zhang · 2024 · Archives of Gerontology and Geriatrics
  53. Targeting calciumopathy for neuroprotection: focus on calcium channels Cav1, Orai1 and P2X7
    Myriam Torres-Rico, Virginia García-Calvo, Adrián Gironda-Martínez, Jorge Pascual-Guerra, Antonio G. Garcı́a, Victoria Maneu · 2024 · Cell Calcium
  54. Ion channel dysregulation and cellular adaptations to alpha-synuclein in stressful pacemakers of the parkinsonian brainstem
    Wei‐Hua Chiu, Nadine Wattad, Joshua A. Goldberg · 2024 · Pharmacology & Therapeutics
  55. Parkinson's Disease and Mitotherapy-Based Approaches towards α-Synucleinopathies
    Vidhi Bhatt, Halak Shukla, Anand Krishna Tiwari · 2024 · Journal of Integrative Neuroscience
  56. Enhanced Spine Stability and Survival Lead to Increases in Dendritic Spine Density as an Early Response to Local Alpha-Synuclein Overexpression in Mouse Prefrontal Cortex
    Peter J. Bosch, Gemma Kerr, Rachel Cole, Charles A. Warwick, L. Wendt, Akash Pradeep, Emma Bagnall, Georgina M. Aldridge · 2024 · Cellular and molecular neurobiology
  57. Identification of the bacterial metabolite aerugine as potential trigger of human dopaminergic neurodegeneration
    Anna‐Katharina Ückert, Sina Rütschlin, Simon Gutbier, Nathalie Christine Wörz, Mahfuzur Rahman Miah, Airton C. Martins, Isa Hauer, Anna‐Katharina Holzer, Birthe Meyburg, Ann-Kathrin Mix et al. · 2023 · Environment International
  58. Extracellular matrix protein anosmin-1 overexpression alters dopaminergic phenotype in the CNS and the PNS with no pathogenic consequences in a MPTP model of Parkinson’s disease
    Javier Villadiego, Roberto García‐Swinburn, Diego García‐González, Rafael Lebrón‐Galán, Verónica Murcia‐Belmonte, Ernesto García‐Roldán, Nela Suárez‐Luna, Cristina Nombela, Miguel Marchena, Fernando de Castro et al. · 2023 · Brain Structure and Function
  59. Music Moves Me in More Ways Than One: An Online Survey Investigating the Everyday Use of Music among People with Parkinson's
    Dawn Rose, Ellen Poliakoff, William R. Young, Michelle Phillips · 2023 · Music & Science
  60. Extraction of Reduced Infrared Biomarker Signatures for the Stratification of Patients Affected by Parkinson’s Disease: An Untargeted Metabolomic Approach
    Kateryna Tkachenko, M. Espinosa, I. Esteban-Dı́ez, J. González-Sáiz, C. Pizarro · 2022 · Chemosensors
  61. Knockdown of small nucleolar RNA host gene 10 (SNHG10) alleviates the injury of human neuroblastoma cells via the miR-1277-5p/insulin substrate receptor 2 axis
    Zhao-Ming Sun, Li-Xiang Song, Jia-Zhen Li · 2021 · Bioengineered · Retracted
  62. Dorsal visual stream is preferentially engaged during externally guided action selection in Parkinson Disease
    Hiro D Sparks, Katy A. Cross, J. Choi, Hristos S. Courellis, J. Thum, E. Koenig, N. Pouratian · 2021 · Clinical Neurophysiology
  63. Trends and Contributing Factors for Prescribing Antipsychotics in Newly Diagnosed Parkinson’s Disease Patients: A Population-Based Study
    Khalid Mubarak Orayj · 2021 · Risk Management and Healthcare Policy
  64. Impact of Footwear and Foot Deformities in patients with Parkinson's disease: A Case-Series Study
    Eloy Trillo Novo, Daniel López‐López, Carmen de Labra, Marta Elena Losa‐Iglesias, Ricardo Vallejo, César Calvo‐Lobo, Carlos Romero Morales, Marta San‐Antolín · 2020 · International Journal of Medical Sciences
  65. Impact of circadian and diurnal rhythms on cellular metabolic function and neurodegenerative diseases
    S. Kendall Smith, Erik S. Musiek · 2020 · International review of neurobiology
  66. Active lifestyle enhances protein expression profile in subjects with Lewy body pathology
    C. Real, C. Suemoto, K. Binda, L. Grinberg, C. Pasqualucci, W. Jacob, R. E. de Lucena Ferretti-Rebustini, R. Nitrini, R. Leite, L. R. de Britto · 2021 · Dementia & Neuropsychologia
  67. Adenosine Receptors and Neuroinflammation
    Antonella Ferrante, Roberta De Simone, Maria Antonietta Ajmone‐Cat, Luisa Minghetti, Patrizia Popoli · 2018 · Springer eBooks
  68. Investigating the association between choroid plexus volume and the pathogenesis of Parkinson's disease.
    D. Yang, Bao-Yi Zhu, Jun-Li Ren, Lingsheng Wang, Haoyang Huang, Zi-Hao Wu, Qiao-Qiao Jin, Yu-Chen Lin, Yang Zhang, Linxuan Zhou et al. · 2025 · Parkinsonism & Related Disorders
  69. Parkinson’s disease: exploring the systemic immune mechanisms through molecular investigations
    Maneesh Mohan, Ashi Mannan, Thakur Gurjeet Singh · 2025 · Inflammopharmacology
  70. Nature’s Remedies: Exploring the Potential of Propolis to Alleviate Non-Motor Manifestations of Parkinson’s Disease
    Kételin Vitória Matias, V Gonçalves, Fulvio Alexandre Scorza, Josef Finsterer, Rozana Mesquita Ciconelli, Carla Alessandra Scorza · 2025 · Molecules
  71. Enhancing striatal acetylcholine facilitates dopamine release and striatal output in parkinsonian mice
    Hongxia Li, Ziluo Chen, Yuyan Tan, Huoqing Luo, Chen Lu, Chao Gao, Xin Shen, Fang Cai, Ji Hu, Shengdi Chen · 2024 · Cell & Bioscience
  72. Longitudinal decline in DAT binding in Parkinson’s disease: connections with sleep disturbances
    Junli Ren, Haobo Xie, Yiyun Weng, Yaoying Ge, Ruotong Yao, Zihan Jiang, Jinxiu Zhang, Yusheng Zhu, Xiaotong Fu, Junchao Wang et al. · 2024 · BMC Medicine
  73. Cortical modulations before lower limb motor blocks are associated with freezing of gait in Parkinson’s disease: an EEG source localization study
    Julianne K. Baarbé, Matt J.N. Brown, Utpal Saha, Stephanie Tran, Anne Weißbach, James Saravanamuttu, Douglas Owen Cheyne, William D. Hutchison, Robert E. Chen · 2024 · Neurobiology of Disease
  74. CAP2 contributes to Parkinson’s disease diagnosed by neutrophil extracellular trap-related immune activity
    Xiaohe Li, Meiling Luo, Hangrui Xu, Lei Jia, Yanan Liang, Qianxi Xu, Yonghui Wang · 2024 · Frontiers in Immunology
  75. Positive relation between dopamine neuron degeneration and metabolic connectivity disruption in the MPTP plus probenecid mouse model of Parkinson's disease.
    M. T. Mazzocco, Marcello Serra, Marco Maspero, A. Coliva, Luca Presotto, Maria Antonietta Casu, Micaela Morelli, R. Moresco, S. Belloli, A. Pinna · 2024 · Experimental Neurology
  76. Multivariate investigation of aging in mouse models expressing the Alzheimer’s protective APOE2 allele: integrating cognitive metrics, brain imaging, and blood transcriptomics
    H. Moon, A. Mahzarnia, Jacques A. Stout, Robert J. Anderson, Madison Strain, Jessica T. Tremblay, Z. Han, A. Niculescu, Anna MacFarlane, Jasmine King et al. · 2023 · Brain Structure and Function
  77. Enhanced spine stability and survival lead to increases in dendritic spine density as an early response to local alpha-synuclein overexpression in mouse prefrontal cortex
    Peter J. Bosch, Gemma Kerr, Rachel Cole, Charles A. Warwick, L. Wendt, Akash Pradeep, Emma Bagnall, Georgina M. Aldridge · 2023 · bioRxiv
  78. Parkinson’s disease progression: Increasing expression of an invariant common core subnetwork
    P. Spetsieris, D. Eidelberg · 2023 · NeuroImage: Clinical
  79. Distribution of Cleaved SNAP-25 in the Rat Brain, following Unilateral Injection of Botulinum Neurotoxin-A into the Striatum
    Friederike Schümann, Oliver Schmitt, Andreas Wree, Alexander Hawlitschka · 2023 · International Journal of Molecular Sciences
  80. Genetic analysis of the LRP10 gene in Chinese patients with Parkinson’s disease
    Na Song, Yan Wang, Liangxing Zhou, Junli Zhang, Fan Wu, Mengpeng Li, Wei Wang, Yan-Ming Liu, Xian-Jie Lu, Qingfa Chen et al. · 2022 · Neurological Sciences
  81. Current Insights on Neurodegeneration by the Italian Proteomics Community
    Tiziana Alberio, Martina Brughera, Marta Lualdi · 2022 · Biomedicines
  82. Can detection and prediction models for Alzheimer’s Disease be applied to Prodromal Parkinson’s Disease using explainable artificial intelligence? A brief report on Digital Neuro Signatures.
    I. Tarnanas, Vlamos · 2021 · Open Research Europe
  83. Impaired age-dependent increases in phosphoglycerate kinase activity in red blood cells of Parkinson's disease patients.
    Yuzo Fujino, T. Kasai, F. Kitani-Morii, T. Ohmichi, Makiko Shinomoto, Kanako Menjo, T. Mizuno · 2021 · Parkinsonism & Related Disorders
  84. All’s well that ends well: an early-phase study testing lower end-session exercise intensity to promote physical activity in patients with Parkinson’s disease
    Layan Fessler, Philippe G. Sarrazin, Annique Smeding, Silvio Maltagliati, Matthieu P. Boisgontier, Boris Cheval · 2021 · Movement & Sport Sciences - Science & Motricité
  85. Gene expression barcode values reveal a potential link between Parkinson’s disease and gastric cancer
    Suyan Tian, Shishun Zhao, Mingbo Tang, Chi Wang · 2021 · Aging
  86. Abnormal eye movements in parkinsonism: a historical view
    T. Ko, A. Brenner, Nicholas Pili Monteiro, M. S. Debastiani, A. C. Nesello, A. Hilbig · 2020 · Arquivos de Neuro-Psiquiatria
  87. Stress-related vulnerability and usefulness of healthcare education in Parkinson's disease: The perception of a group of family caregivers, a cross-sectional study
    Enrico Di Stasio, Emanuele Di Simone, Arianna Galeti, Daniele Donati, Chiara Guidotti, Daniela Tartaglini, Massimiliano Chiarini, Massimo Marano, Marco Di Muzio, Claudia Cianfrocca · 2019 · Applied Nursing Research
  88. Endogenous protection against the 6-OHDA model of Parkinson's disease in the Amazonian rodent Proechimys
    Márcia Marques, Caroline Cristiano Real, Daniella Balduino Victorino, Luiz Roberto Britto, Ésper A. Cavalheiro, Fulvio Alexandre Scorza, Henrique Ballalai Ferraz, Carla Alessandra Scorza · 2019 · Neuroscience Letters
  89. Parkinson-Erkrankung und Neuroinflammation – Zelluläre Pathologie, Mechanismen und therapeutische Optionen
    Lars Tönges, Judith Metzdorf, Samis M. A. Zella · 2018 · Fortschritte der Neurologie · Psychiatrie
  90. Dopamine Homeostasis and Role of VMAT2 in Neurodegeneration
    Eugene V. Mosharov · 2021 · Springer eBooks
  91. Therapeutic potential of KATP channels in the attenuation of Parkinson's disease pathogenesis and progression – A review
    Barbara Gundi, Hio Lam Ho, Xinyang Zhang, Amanda He, Danielle Xin, Ana Flávia Fernandes Ferreira, Luiz Roberto Giogetti de Britto, Zhong‐Ping Feng, Hong‐Shuo Sun · 2025 · Neurochemistry International
  92. Whole transcriptome analysis of peripheral blood mononuclear cells from de novo and drug-naive Parkinson's disease patients
    F. Navarrete, Marina Guillot-Fernández, Lorena Martínez-Hostyn, D. Navarro, J. A. Molina, J. López-Atalaya, J. Manzanares · 2025 · Neurotherapeutics
  93. Traditional Chinese exercises for motor symptoms and mobility in patients with Parkinson's disease: a systematic review and meta-analysis
    Fumei Yuan, Hong Wang · 2025 · Frontiers in Aging Neuroscience
  94. Deep Brain Stimulation rescues the homeostasis disruption of circulating D- and L-amino acids level in men with Parkinson’s Disease
    T. Nuzzo, F. Carrillo, Marcello Serra, C. Gentile, A. di Maio, A. Pizzella, S. Pietracupa, N. Modugno, F. Errico, T. Esposito et al. · 2025 · bioRxiv
  95. Acupuncture for Parkinson’s Disease: A Narrative Review of Clinical Efficacy and Mechanistic Insights
    Nan‐Nan Yu, Dianjia Sun, Ma Lin, Qichen Han, Rui Song, Yuhao Wang · 2025 · Neuropsychiatric Disease and Treatment
  96. Upregulation of PD-1 on Peripheral T cells Subsets is Associated with Parkinson's Disease
    Zhiling Zhang, Panghai Ye, Wei-Xin Kong, Jin Li, Si Zhu, Yu-Wan Lin, Pingyi Xu, Wenyuan Guo · 2025 · Molecular Neurobiology
  97. Machine learning in neuroimaging and computational pathophysiology of Parkinson’s disease: A comprehensive review and meta-analysis
    Khushi Sharma, Manjula Shanbhog, Kuljeet Singh · 2025 · Asian Journal of Psychiatry
  98. Comparing the impact of low frequency vs high frequency deep brain stimulation in Patient’s with Parkinson’s disease: A systematic review
    Govind Singh Mann, Binay Kumar Panjiyar, MD Parbej Allam, Fnu Asifa, Ahsan Ullah, Shivangi Jha · 2025 · Brain Disorders
  99. The HALP score differs among sporadic and familial Parkinson's disease
    Wen Zhou, Qingqing Xia, Duan Liu, Jun Ying Li, Liang Gong · 2025 · Parkinsonism & Related Disorders
  100. Mapping brain morphology to cognitive deficits: a study on PD-CRS scores in Parkinson’s disease with mild cognitive impairment
    Pedro Renato de Paula Brandão, Danilo Assis Pereira, Talyta Cortez Grippe, Diógenes Diego de Carvalho Bispo, Fernando Bisinoto Maluf, Ricardo Titze‐de‐Almeida, Brenda Macedo de Almeida e Castro, Renato P. Munhoz, Maria Clotilde Henriques Tavares, Francisco Cardoso · 2024 · Frontiers in Neuroanatomy